参考文献/References:
[1]周可林,陈绍红.伤酒导致多脏器损伤的中医研究[J].中国社区医师,2016,32(27):14,16.
[2]周新兰,任洪丽.脂肪肝中医病因病机探析[J].辽宁中医药大学学报,2014,16(6):173-175.
[3]曾民德.脂肪肝发病机制及其“二次打击”假设[J].中华消化杂志,2002,22(3):167-168.
[4]张文宇,马满玲.细胞色素P4502E1与乙醇代谢相关的肝损伤研究进展[J].西部医学,2016,28(11):1625-1628.
[5]伍振辉,孟娴,胡佳伟,等.TLR4-MyD88-NF-kB信号通路与肝炎-肝纤维化-肝癌轴相关性研究进展[J].国际药学研究杂志,2017,44(05):396-401.
[6]张子杰,袁征,闫振宇.肝细胞癌组织中TLR4、MyD88、NF-kB表达量及其与临床病理特征的相关性分析[J].中国现代医学杂志,2017,27(04):55-58.
[7]吴圣伟.肠-肝轴在酒精性肝病发生发展中的作用[D].蚌埠医学院,2016.
[8]楼招欢,王军伟.“肠-肝轴”在酒精性肝病中的作用及乌药的干预研究进展[J].浙江中医药大学学报,2017,41(06):545-547.
[9]王全楚,步子恒,李青上.肠肝轴的现代概念及其在肝脏疾病中的作用[J].胃肠病学和肝病学杂志,2015,24(09):1155-1158.
[10]马臻奇,赵彬,郑有花.核因子κB、转化因子β1与酒精性肝病的关系[J].青海医药杂志,2016,46(10):78-80.
[11]Park JK,Shao M,Kim MY,et al.An endoplasmic reticulum protein,Nogo‐B,facilitates alcoholic liver disease through regulation of kupffer cell polarization[J].Hepatology,2017,65(5):1720-1734.
[12]Zhou H,Yu M,Zhao J,et al.IRAKM‐Mincle axis links cell death to inflammation:Pathophysiological implications for chronic alcoholic liver disease[J].Hepatology,2016,64(6):1978-1993.
[13]Wiest R,Albillos A,Trauner M,et al.Targeting the gut-liver axis in liver disease[J].Journal of Hepatology,2017,67(5):1084.
[14]Eguchi A,Lazaro RG,Wang J,et al.Extracelluar vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood[J].Hepatology,2017,65(2):475-490.
[15]Blaya D,Coll M,Rodrigotorres D,et al.Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation[J].Gut,2016,65(9):1535-1545.
[16]Hagstrm H,Stl P,Hultcrantz R,et al.Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study[J].Journal of Hepatology,2016,65(2):363-368.
[17]Andreasson A,Carlsson A C,nnerhag K,et al.Waist Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index:A Population-based Cohort Study[J].Clin Gastroenterol Hepatol,2017,15(8):1294-1301.
[18]严清霜.酒精性肝病中医证素分布规律研究[D].福建中医药大学,2012.
[19]韩相国,鹿守印,罗爱琴,等.超声诊断脂肪肝与酒精肝的临床价值[J].实用医学影像杂志,2017,18(1):88-89.
[20]沈国良,高雅文,王丽萍,等.脂肪肝辨证分型与B超分度间的关系研究[J].浙江中医杂志,2004(03):14-15.
[21]张婷,董淑娟,韩艳俊.脂肪衰减参数在不同中医证型脂肪肝诊断中的应用[J].河南中医,2016,36(11):1940-1942.
[22]姚志山,张会玲,刘丁丁,等.酒精性肝病中医证型与肝功能、血脂的相关性分析[J].中西医结合肝病杂志,2016,26(01):48-50.
[23]黄群,张传涛,刘业方.中医“实脾”理论治疗现代肝病的理论及实践[J].浙江中医药大学学报,2017,41(03):223-225.
[24]邓翠丽.以“治未病”思想为指导的中医健康管理在非酒精性脂肪肝中的应用[D].广州中医药大学,2011.
[25]马成艳.酒精性肝病患者行心理治疗与不行心理治疗的预后戒酒效果比较[J].药物与临床,2015,9(20):409.
[26]田丽艳,陆伦根.2010年美国肝病学会酒精性肝病指南解读[J].中国医学前沿杂志(电子版),2011,3(1):14-16.
[27]黎俊,韩涛.酒精性肝病与营养不良[J].实用肝脏病杂志,2012,15(03):191-193.
[28]汤英.观察中药降酶汤加西医常规护肝治疗慢性脂肪肝、酒精肝的临床疗效[J].中国医药指南,2015,13(23):202-203.
[29]黄敏贤,吴谦,潘竞锵,等.茵陈蒿汤对酒精性诱导脂肪肝大鼠的护肝、抗自由基损伤和降血脂作用[J].海峡药学,2015,27(02):21-24.
[30]盛国光.中医肝病临床辨治思路探析[J].中西医结合肝病杂志,2006(02):65-67.
[31]詹宗颖,孙明瑜.酒精性肝病的中医治疗及研究进展[J].四川中医,2014,32(10):182-186.
[32]沈靖,黄芳芳,王珠美.戒酒互助小组对酒精性肝病患者饮酒行为自我管理的影响[J].世界华人消化杂志,2017,25(10):904-908.
[33]王迎春,孔维宗.酒精性肝病的营养支持[J].实用肝脏病杂志,2014,17(05):456-458.
[34]邬玲玲,竺雪红,李晓燕.酒精性肝病合并酒精戒断综合征的护理[J].护理与康复,2012,11(12):1132-1133.
[35]展玉涛,孙洪强.酒精戒断综合征的治疗[J].中华消化病与影像杂志(电子版),2014,4(3):149-151.
[36]管增淦,刘克喜.右美托咪定超说明书应用进展[J].中国新药与临床杂志,2015,34(01):1-4.
[37]付守芝,吴红勇,杜晓娟,等.纳洛酮辅助治疗重症酒精戒断综合征25例[J].医药导报,2008(11):1340-1342.
[38]谢迎春.酒精戒断综合征误诊肝性脑病1例[J].临床合理用药杂志,2015,8(26):167.
[39]徐静,李平,耿家宝,等.酒精性肝硬化合并戒断综合征误诊1例[J].肝脏,2015,20(10):840.
[40]张岱,王炳元.酒精性肝病常见临床综合征[J].临床肝胆病杂志,2014,30(2):121-123.
[41]何强,徐有青.酒精性肝病相关临床综合征[J].中国临床医生,2014,42(10):9-14.
[42]谢雯,赵红,成军.S-腺苷蛋氨酸临床研究进展[J].世界华人消化杂志,2010,18(33):3553-3558.
[43]双环醇片临床应用专家委员会.双环醇片临床应用专家建议[J].中华实验和临床感染病杂志电子版,2014,8(6):875-879.
[44]刘晨琪,高丽,霍小位,等.诸葛菜种子水提物对急性酒精肝损伤小鼠的保护作用[J].现代食品科技,2017,33(08):7-11,79.
[45]叶文斌,樊亮,王昱,等.黄果槲寄生果实多糖对急性酒精肝损伤小鼠的保护作用[J].安徽农业大学学报,2017,44(02):218-223.
[46]周源,廖兵,王旭睿,等.姜蚬护肝汤对酒精性肝损伤小鼠模型的保护作用及机制研究[J].中国药师,2017,20(06):1042-1045.
[47]张志毕,杨晖,张媛,等.迷迭香提取物对小鼠急性酒精肝模型保护作用研究[J].天然产物研究与开发,2017,29(02):229-234.
[48]Zhu L,Fu R,Liu X,et al.Soyasaponin Bb Protects Rat Hepatocytes from Alcohol-Induced Oxidative Stress by Inducing Heme Oxygenase-1[J].Pharmacognosy Magazine,2016,12(48):302-306.
[49]Mathurin P,Hadengue A,Bataller R.EASL Clinical Practical Guidelines:Management of Alcoholic Liver Disease[J].Journal of Hepatology,2012,57(2):399-420.
[50]Mitchell MC,Friedman LS,Mcclain CJ.Medical Management of Severe Alcoholic Hepatitis:Expert Review from the Clinical Practice Updates Committee of the AGA Institute[J].Clin Gastroenterol Hepatol,2017,15(1):5-12.
[51]Haque TR.Intestinal microbiota in liver disease[J].Best Practice&Research Clinical Gastroenterology,2016,30(1):133-142.
[52]Hotaik S,Seung WK,Meegun H,et al.Microbiota-based treatments in alcoholic liver disease[J].World Journal of Gastroenterology,2016,22(29):6673-6682.
[53]臧月,王生,刘楠,等.肠道菌群失调介导酒精性肝病发生发展的机制研究进展[J].中国药理学通报,2016,32(04):451-455.
相似文献/References:
[1]张君红,李洪梅,井 洁,等.溃疡性结肠炎中西医结合治疗研究[J].医学信息,2018,31(09):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
ZHANG Jun-hong,LI Hong-mei,JING Jie,et al.Study on the Treatment of Ulcerative Colitis with Integrated Traditional Chinese and Western Medicine[J].Journal of Medical Information,2018,31(15):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
[2]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Journal of Medical Information,2022,35(15):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[3]陈雪梅,肖 瑶.广州地区西医现代期刊文献研究[J].医学信息,2019,32(03):6.[doi:10.3969/j.issn.1006-1959.2019.03.003]
CHEN Xue-mei,XIAO Yao.Research on Western Modern Periodicals of Medicine Literature in Guangzhou Area[J].Journal of Medical Information,2019,32(15):6.[doi:10.3969/j.issn.1006-1959.2019.03.003]
[4]刘 浩,黄 娟.中西医结合临床专业外科基本技术培训模式改革研究[J].医学信息,2019,32(03):25.[doi:10.3969/j.issn.1006-1959.2019.03.009]
LIU Hao,HUANG Juan.Research on the Reform of Basic Technical Training Mode of Clinical Specialty in Integrated Traditional Chinese and Western Medicine[J].Journal of Medical Information,2019,32(15):25.[doi:10.3969/j.issn.1006-1959.2019.03.009]
[5]李 英,欧宁江,孔俊绯.中西医结合治疗变应性结膜炎的临床观察[J].医学信息,2018,31(19):148.[doi:10.3969/j.issn.1006-1959.2018.19.045]
LI Ying,OU Ning-jiang,KONG Jun-fei.Clinical Observation on Treatment of Allergic Conjunctivitis with Combination of Traditional Chinese Medicine and Western Medicine[J].Journal of Medical Information,2018,31(15):148.[doi:10.3969/j.issn.1006-1959.2018.19.045]
[6]裴金娜,刘 静,梁震峰,等.中西医结合治疗急性前壁ST段抬高型心肌梗死的临床疗效[J].医学信息,2019,32(08):166.[doi:10.3969/j.issn.1006-1959.2019.08.052]
PEI Jin-na,LIU Jing,LIANG Zhen-feng,et al.Clinical Efficacy of Integrated Traditional Chinese and Western Medicine in the Treatment of Acute Anterior Wall ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2019,32(15):166.[doi:10.3969/j.issn.1006-1959.2019.08.052]
[7]姜小娥.中西医结合治疗慢性乙肝的临床观察[J].医学信息,2019,32(10):160.[doi:10.3969/j.issn.1006-1959.2019.10.053]
JIANG Xiao-e.Clinical Observation on Treatment of Chronic Hepatitis B with Integrative Medicine Therapy[J].Journal of Medical Information,2019,32(15):160.[doi:10.3969/j.issn.1006-1959.2019.10.053]
[8]阮兴秋,莫 鹏.五海瘿瘤丸联合微波消融术治疗乳房良性肿瘤临床研究[J].医学信息,2019,32(11):81.[doi:10.3969/j.issn.1006-1959.2019.11.022]
RUAN Xing-qiu,MO Peng.Clinical Study on Treatment of Benign Breast Tumors with
Wuhai Yingliu Pills Combined with Microwave Ablation[J].Journal of Medical Information,2019,32(15):81.[doi:10.3969/j.issn.1006-1959.2019.11.022]
[9]邓 伟.冠脉无复流的危险因素及治疗[J].医学信息,2021,34(03):43.[doi:10.3969/j.issn.1006-1959.2021.03.013]
DENG Wei.Risk Factors and Treatment of No-reflow of Coronary Artery[J].Journal of Medical Information,2021,34(15):43.[doi:10.3969/j.issn.1006-1959.2021.03.013]
[10]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and
Western Medicine[J].Journal of Medical Information,2019,32(15):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]